Newly Added Compounds
We're pleased to announce the addition of 11 new research compounds to our catalog this quarter, spanning next-generation metabolic peptides, receptor agonists, and performance research molecules:
- RT (LY3437943) — Triple GIP/GLP-1/glucagon receptor agonist (CAS#: 2381089-83-2)
- Survodutide (BI 456906) — Dual glucagon/GLP-1 receptor agonist (CAS#: 2381089-84-3)
- Mazdutide (IBI362) — GLP-1/glucagon dual agonist (CAS#: 3037634-25-3)
- SLU-PP-332 — ERRα/β/γ pan-agonist, exercise mimetic (CAS#: 3037305-03-0)
- ACE-031 (ACVR2B-Fc) — Myostatin/activin decoy receptor (CAS#: 879685-55-2)
- AICAR — AMPK activator, metabolic research (CAS#: 2627-69-2)
- Cagrilintide + Semaglutide (CagriSema) — Fixed-ratio dual-mechanism blend
- HMG — FSH/LH gonadotropin blend (CAS#: 9002-61-7)
- Gonadorelin — GnRH decapeptide (CAS#: 33384-29-7)
- Thymalin — Thymus-derived polypeptide complex (CAS#: 83089-70-7)
- IGF-DES — Truncated IGF-1, reduced IGFBP affinity (CAS#: 124431-57-3)
All new compounds are available with ≥99% purity, independently verified by third-party HPLC/MS analysis. Certificates of Analysis are accessible via our COA database.
Availability & Packaging
All new products ship as lyophilized powder in 10-vial box packaging. Multiple size options are available depending on compound. Orders placed before 2 PM (Monday–Friday) ship the same business day.
View the Full Catalog
Browse all available research compounds — including the newly added products — on our products page.